
    
      To assess the effect of PRO044 at different dose levels in subjects with Duchenne muscular
      dystrophy To assess the safety and tolerability of PRO044 at different dose levels in
      subjects with Duchenne muscular dystrophy To determine the pharmacokinetics of PRO044 at
      different dose levels after subcutaneous and intravenous administration in subjects with
      Duchenne muscular dystrophy.
    
  